The American Journal of Managed Care

Medicare Insulin Savings Model Cuts Costs, Boosts Access, Report Finds

The Medicare program effectively reduced insulin costs, improved adherence, and increased plan enrollment, benefiting both ...
Becker's Hospital Review

Medicare insulin program cuts costs, improves care: RAND

CMS' Part D Senior Savings Model effectively increased insulin use while reducing out-of-pocket costs among Medicare beneficiaries, according to a ...
Pharmaceutical Commerce

Pharma Pulse: CDC Expands COVID-19 Vaccine Guidance, Medicare Model Cuts Insulin Costs, and Lilly Invests in Houston Facility

This episode of Pharma Pulse covers the CDC’s unanimous vote to broaden COVID-19 vaccine recommendations for all adults, new ...
The Pharma Letter

Report notes wins and trade-offs from Medicare insulin cost program

A federal initiative to cap out-of-pocket insulin costs for Medicare beneficiaries cut spending and boosted adherence, ...
Health Affairs

Medicare Part D Redesign Savings May Be Lower For Beneficiaries With Spending Below The Out-Of-Pocket Cap

The Medicare prescription drug plan redesign under the Inflation Reduction Act of 2022 aims to simplify the Part D benefit while capping out-of-pocket spending for Part D–covered drugs. Whether and ...
Hosted on MSN

Trump proposes major Medicare drug plan changes

President Donald Trump is expected to sign an executive order soon to lower the cost of prescription drugs for Medicare beneficiaries. The order would implement a “most favored nation” policy, tying ...